Atlas market file · Equity · United States
Reliance Global Group, Inc.EZRA
- Last close
- 2.57
- Change
- +7.98%
- 96-bar range
- 1.75 – 9.16
- As of
- 6 Aug 2026
Reliance Global Group, Inc. is an insurance agents, brokers & service issuer listed as EZRA on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
EZRA
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-97.77% over the window).
Source rail: Yahoo Finance chart API (EZRA). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for EZRA. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
EZRA public profile
Insurance agents, brokers & service issuer. Reliance Global Group, Inc. is connected to current market context, cited company sources and its retained research file.
Reliance Global Group, Inc. trades as EZRA on NASDAQ. Reliance Global Group, Inc. (EZRA) has a latest verified close of 2.57, up 7.98%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files EZRA under USA Stocks for browsing.
What changed for Reliance Global Group, Inc. today
Reliance Global Group, Inc. has been making headlines with its recent appointments and product developments, but the real story lies in its financials. The company's latest 10-Q filing shows a revenue of $3.8M for the period ending 2026-03-31, and a net income loss of $-1.5M. The company's strategy of organic expansion and acquisitions is aimed at growing its business, but it remains to be seen if this will eventually lead to profitability.
The company's AI-powered insurance products are a key part of its growth strategy, and the appointment of a new CTO from Coinbase and Capital One is a significant move in this direction. However, the company's cash flow situation is a concern, with a net cash used in operating activities of $-571,174 for the period ending 2026-03-31.
The company's filings and earnings reports are available on the SEC EDGAR website, and investors can find more information on the company's official website. The Quarterly Earnings section provides a detailed overview of the company's financial performance, and the Investors & Media section offers updates on the company's strategy and developments.
The company's product offerings and pipeline are a key part of its growth strategy, and the launch of LifeSci Global, its dedicated life sciences platform, is a significant development. The company's partnerships and collaborations, such as the one with Innervate Radiopharmaceuticals, are also worth watching.
The company's stock performance and market data can be found on financial websites and platforms, but it's essential to look beyond the numbers and understand the underlying business and market mechanisms. The company's filings and earnings reports provide a wealth of information on its financial performance and growth strategy.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
EZRA technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on EZRA
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep EZRA research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
EZRA FAQ
What is Reliance Global Group, Inc. (EZRA)?Reliance Global Group, Inc. (EZRA) has a latest verified close of 2.57, up 7.98%, dated 6 Aug 2026. Use this page to check the price chart, company context,...
Reliance Global Group, Inc. (EZRA) has a latest verified close of 2.57, up 7.98%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for EZRA?Reliance Global Group, Inc. (EZRA) has a latest verified close of 2.57, up 7.98%, dated 6 Aug 2026. It brings the latest available chart, company context, cited...
Reliance Global Group, Inc. (EZRA) has a latest verified close of 2.57, up 7.98%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files EZRA under USA Stocks for browsing.
How often is the EZRA page updated?The EZRA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The EZRA public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for EZRA?The EZRA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:EZRA. SEC EDGAR provides the filing anchor for this issuer. The page separates...
The EZRA file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:EZRA. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on EZRA?Yes. The workstation can open EZRA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open EZRA, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this EZRA page investment advice?No. The EZRA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The EZRA page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →